| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 59 | 2020 | 511 | 8.910 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 22 | 2023 | 43 | 8.330 |
Why?
|
| DNA-Binding Proteins | 55 | 2020 | 482 | 7.860 |
Why?
|
| Nuclear Proteins | 31 | 2010 | 245 | 3.520 |
Why?
|
| Prostatic Neoplasms | 7 | 2023 | 270 | 3.040 |
Why?
|
| Promoter Regions, Genetic | 33 | 2020 | 333 | 3.030 |
Why?
|
| Trans-Activators | 22 | 2005 | 113 | 2.880 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2020 | 445 | 2.780 |
Why?
|
| Transcriptional Activation | 21 | 2018 | 86 | 2.140 |
Why?
|
| Transcription, Genetic | 34 | 2020 | 400 | 1.990 |
Why?
|
| Histone Demethylases | 6 | 2023 | 9 | 1.890 |
Why?
|
| Proto-Oncogene Proteins | 18 | 2012 | 139 | 1.770 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2023 | 114 | 1.530 |
Why?
|
| Matrix Metalloproteinase 1 | 9 | 2023 | 16 | 1.370 |
Why?
|
| Cell Line | 26 | 2019 | 672 | 1.330 |
Why?
|
| Receptor, ErbB-2 | 9 | 2008 | 32 | 1.330 |
Why?
|
| DEAD-box RNA Helicases | 5 | 2010 | 26 | 1.320 |
Why?
|
| Humans | 95 | 2023 | 26846 | 1.270 |
Why?
|
| Colorectal Neoplasms | 2 | 2020 | 133 | 1.260 |
Why?
|
| Proto-Oncogene Proteins c-ets | 7 | 2013 | 18 | 1.240 |
Why?
|
| Gene Expression Regulation | 16 | 2014 | 627 | 1.240 |
Why?
|
| Protein Binding | 23 | 2020 | 631 | 1.220 |
Why?
|
| Cell Proliferation | 12 | 2020 | 771 | 1.210 |
Why?
|
| Phosphorylation | 32 | 2020 | 560 | 1.080 |
Why?
|
| Colonic Neoplasms | 3 | 2014 | 117 | 1.030 |
Why?
|
| Animals | 53 | 2020 | 9962 | 1.000 |
Why?
|
| Telomerase | 5 | 2006 | 37 | 0.980 |
Why?
|
| Neoplasms | 6 | 2020 | 756 | 0.970 |
Why?
|
| Protein Kinases | 9 | 2003 | 143 | 0.920 |
Why?
|
| Cell Cycle Proteins | 6 | 2016 | 184 | 0.910 |
Why?
|
| Breast Neoplasms | 10 | 2015 | 441 | 0.890 |
Why?
|
| Cell Line, Tumor | 15 | 2020 | 1263 | 0.890 |
Why?
|
| Transforming Growth Factor beta | 7 | 2005 | 77 | 0.890 |
Why?
|
| Signal Transduction | 19 | 2019 | 1344 | 0.840 |
Why?
|
| Repressor Proteins | 5 | 2010 | 114 | 0.830 |
Why?
|
| Molecular Sequence Data | 27 | 2014 | 1036 | 0.830 |
Why?
|
| Mitogen-Activated Protein Kinases | 9 | 2003 | 83 | 0.810 |
Why?
|
| Binding Sites | 18 | 2014 | 338 | 0.790 |
Why?
|
| Histones | 4 | 2017 | 90 | 0.790 |
Why?
|
| Sarcoma, Ewing | 4 | 2005 | 14 | 0.770 |
Why?
|
| Acetyltransferases | 5 | 2004 | 36 | 0.760 |
Why?
|
| Base Sequence | 20 | 2012 | 573 | 0.760 |
Why?
|
| Smad Proteins | 4 | 2019 | 18 | 0.760 |
Why?
|
| Cell Nucleus | 12 | 2007 | 135 | 0.760 |
Why?
|
| Transfection | 19 | 2010 | 312 | 0.740 |
Why?
|
| Apoptosis | 4 | 2012 | 739 | 0.740 |
Why?
|
| Biomarkers, Tumor | 3 | 2013 | 377 | 0.730 |
Why?
|
| Up-Regulation | 5 | 2012 | 240 | 0.720 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2020 | 20 | 0.710 |
Why?
|
| Mice | 22 | 2020 | 4406 | 0.710 |
Why?
|
| Epigenomics | 1 | 2020 | 29 | 0.700 |
Why?
|
| Oxidoreductases, N-Demethylating | 6 | 2009 | 7 | 0.660 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2012 | 98 | 0.650 |
Why?
|
| Phosphoproteins | 2 | 2016 | 115 | 0.640 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 60 | 0.630 |
Why?
|
| Receptors, Androgen | 2 | 2009 | 25 | 0.620 |
Why?
|
| p300-CBP Transcription Factors | 6 | 2010 | 13 | 0.620 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2012 | 117 | 0.610 |
Why?
|
| Matrix Metalloproteinase 7 | 3 | 2013 | 13 | 0.600 |
Why?
|
| Neoplasm Proteins | 3 | 2016 | 122 | 0.600 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 160 | 0.600 |
Why?
|
| RNA-Binding Protein EWS | 4 | 2005 | 7 | 0.590 |
Why?
|
| Luciferases | 9 | 2012 | 49 | 0.580 |
Why?
|
| beta Catenin | 3 | 2014 | 62 | 0.580 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2020 | 13 | 0.570 |
Why?
|
| HEK293 Cells | 6 | 2019 | 173 | 0.560 |
Why?
|
| Amino Acid Sequence | 20 | 2014 | 674 | 0.550 |
Why?
|
| HCT116 Cells | 4 | 2020 | 53 | 0.530 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2014 | 14 | 0.510 |
Why?
|
| Retroviridae Proteins, Oncogenic | 7 | 1996 | 9 | 0.510 |
Why?
|
| Embryo, Mammalian | 3 | 2012 | 28 | 0.510 |
Why?
|
| Genes, fos | 7 | 1997 | 13 | 0.510 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2019 | 10 | 0.510 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 1999 | 31 | 0.500 |
Why?
|
| HeLa Cells | 16 | 2010 | 206 | 0.490 |
Why?
|
| Sp1 Transcription Factor | 2 | 2005 | 17 | 0.480 |
Why?
|
| Epigenesis, Genetic | 4 | 2017 | 145 | 0.470 |
Why?
|
| Histone Acetyltransferases | 5 | 2007 | 15 | 0.470 |
Why?
|
| Oncogene Proteins | 3 | 2012 | 21 | 0.470 |
Why?
|
| Mutation | 8 | 2020 | 820 | 0.460 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2004 | 17 | 0.460 |
Why?
|
| Cell Cycle | 3 | 2012 | 155 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2010 | 9 | 0.440 |
Why?
|
| 14-3-3 Proteins | 1 | 2013 | 9 | 0.440 |
Why?
|
| Exoribonucleases | 1 | 2013 | 20 | 0.440 |
Why?
|
| Male | 13 | 2023 | 12875 | 0.430 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2003 | 3 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-fos | 5 | 2011 | 13 | 0.420 |
Why?
|
| Tumor Cells, Cultured | 8 | 2012 | 310 | 0.420 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 194 | 0.420 |
Why?
|
| Mice, Knockout | 6 | 2020 | 782 | 0.420 |
Why?
|
| Gene Expression | 6 | 2018 | 406 | 0.410 |
Why?
|
| SOX9 Transcription Factor | 1 | 2012 | 12 | 0.410 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2012 | 6 | 0.400 |
Why?
|
| Smad3 Protein | 3 | 2007 | 10 | 0.400 |
Why?
|
| Embryonic Development | 1 | 2012 | 21 | 0.400 |
Why?
|
| Testis | 1 | 2012 | 39 | 0.400 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2006 | 228 | 0.390 |
Why?
|
| Early Growth Response Transcription Factors | 3 | 2010 | 3 | 0.390 |
Why?
|
| Carcinogenesis | 2 | 2023 | 79 | 0.390 |
Why?
|
| Kidney | 6 | 2007 | 275 | 0.380 |
Why?
|
| E1A-Associated p300 Protein | 3 | 2007 | 3 | 0.380 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 439 | 0.380 |
Why?
|
| Down-Regulation | 6 | 2013 | 197 | 0.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 324 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2017 | 100 | 0.370 |
Why?
|
| Cells, Cultured | 10 | 2019 | 970 | 0.360 |
Why?
|
| Female | 17 | 2019 | 14463 | 0.350 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2010 | 3 | 0.350 |
Why?
|
| DNA | 10 | 2003 | 365 | 0.350 |
Why?
|
| Lysine | 3 | 2023 | 71 | 0.340 |
Why?
|
| RNA Interference | 3 | 2016 | 135 | 0.340 |
Why?
|
| Bone Neoplasms | 3 | 2011 | 27 | 0.340 |
Why?
|
| Methylation | 3 | 2023 | 21 | 0.330 |
Why?
|
| Protein Structure, Tertiary | 7 | 2007 | 283 | 0.330 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2014 | 276 | 0.330 |
Why?
|
| Carrier Proteins | 3 | 2010 | 245 | 0.310 |
Why?
|
| Rabbits | 9 | 2002 | 272 | 0.310 |
Why?
|
| Electrophoretic Mobility Shift Assay | 4 | 2012 | 50 | 0.300 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2012 | 28 | 0.290 |
Why?
|
| Genes, Reporter | 8 | 2014 | 88 | 0.290 |
Why?
|
| Oxidoreductases | 1 | 2007 | 56 | 0.280 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2006 | 5 | 0.280 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2011 | 33 | 0.270 |
Why?
|
| ras Proteins | 3 | 2004 | 43 | 0.270 |
Why?
|
| Serpins | 2 | 2017 | 31 | 0.250 |
Why?
|
| Proteins | 1 | 2007 | 244 | 0.250 |
Why?
|
| Blotting, Western | 4 | 2012 | 503 | 0.250 |
Why?
|
| Models, Biological | 7 | 2011 | 446 | 0.250 |
Why?
|
| CREB-Binding Protein | 7 | 2002 | 10 | 0.250 |
Why?
|
| Mice, Transgenic | 4 | 2017 | 486 | 0.250 |
Why?
|
| Cell Movement | 4 | 2019 | 353 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 2004 | 6 | 0.250 |
Why?
|
| Wnt Signaling Pathway | 2 | 2017 | 54 | 0.250 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2018 | 24 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 176 | 0.240 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2002 | 33 | 0.240 |
Why?
|
| Genetic Vectors | 4 | 2014 | 107 | 0.240 |
Why?
|
| Osteosarcoma | 4 | 2012 | 14 | 0.230 |
Why?
|
| Antigens, Protozoan | 1 | 2004 | 8 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 1475 | 0.230 |
Why?
|
| Disease Progression | 3 | 2019 | 450 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 12 | 0.230 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2003 | 5 | 0.220 |
Why?
|
| Histidine | 3 | 1992 | 50 | 0.220 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2003 | 45 | 0.220 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2020 | 129 | 0.220 |
Why?
|
| HT29 Cells | 2 | 2014 | 19 | 0.220 |
Why?
|
| Translocation, Genetic | 3 | 2012 | 22 | 0.220 |
Why?
|
| RNA Helicases | 1 | 2003 | 8 | 0.210 |
Why?
|
| Cloning, Molecular | 6 | 2006 | 205 | 0.210 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 93 | 0.210 |
Why?
|
| Endometrial Neoplasms | 1 | 2005 | 184 | 0.210 |
Why?
|
| Genes, erbB-2 | 1 | 2002 | 3 | 0.200 |
Why?
|
| Neurodegenerative Diseases | 1 | 2002 | 21 | 0.200 |
Why?
|
| MicroRNAs | 2 | 2016 | 280 | 0.200 |
Why?
|
| Neoplasm Invasiveness | 2 | 2013 | 180 | 0.200 |
Why?
|
| ets-Domain Protein Elk-1 | 8 | 1997 | 13 | 0.200 |
Why?
|
| Enzyme Inhibitors | 4 | 2009 | 247 | 0.190 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 28 | 0.190 |
Why?
|
| Estrogen Receptor alpha | 2 | 2012 | 26 | 0.190 |
Why?
|
| Acetylation | 3 | 2010 | 36 | 0.190 |
Why?
|
| RNA, Messenger | 5 | 2012 | 646 | 0.190 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 8 | 0.180 |
Why?
|
| Serum Response Factor | 8 | 1996 | 11 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 1 | 0.180 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 34 | 0.180 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 7 | 0.180 |
Why?
|
| Mice, Nude | 3 | 2019 | 313 | 0.180 |
Why?
|
| Podocytes | 3 | 2019 | 10 | 0.180 |
Why?
|
| Time Factors | 2 | 2020 | 1563 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 1997 | 26 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 57 | 0.170 |
Why?
|
| Survival Analysis | 1 | 2020 | 276 | 0.170 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 152 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2007 | 110 | 0.170 |
Why?
|
| Cyclin D1 | 2 | 2014 | 38 | 0.170 |
Why?
|
| Cadmium Poisoning | 1 | 2019 | 1 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2013 | 466 | 0.170 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 8 | 0.170 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2018 | 80 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2014 | 40 | 0.170 |
Why?
|
| Dimerization | 3 | 2006 | 75 | 0.170 |
Why?
|
| Receptors, Growth Factor | 1 | 1999 | 6 | 0.170 |
Why?
|
| Apelin Receptors | 1 | 2019 | 11 | 0.160 |
Why?
|
| Cryptochromes | 1 | 2018 | 1 | 0.160 |
Why?
|
| Extracellular Vesicles | 1 | 2019 | 30 | 0.160 |
Why?
|
| MAP Kinase Kinase 4 | 3 | 2014 | 12 | 0.160 |
Why?
|
| Wnt Proteins | 2 | 2017 | 32 | 0.160 |
Why?
|
| Smad7 Protein | 5 | 2005 | 6 | 0.160 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 151 | 0.150 |
Why?
|
| Astrocytes | 1 | 1999 | 73 | 0.150 |
Why?
|
| Mitochondria | 2 | 2019 | 333 | 0.150 |
Why?
|
| Oryzias | 2 | 2019 | 4 | 0.150 |
Why?
|
| Drosophila Proteins | 3 | 1997 | 43 | 0.150 |
Why?
|
| Isochromosomes | 1 | 1997 | 1 | 0.150 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2017 | 15 | 0.150 |
Why?
|
| Germinoma | 1 | 1997 | 4 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1997 | 12 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 1999 | 189 | 0.150 |
Why?
|
| Testicular Neoplasms | 1 | 1997 | 15 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 38 | 0.140 |
Why?
|
| Microtubules | 2 | 2017 | 89 | 0.140 |
Why?
|
| Antigens, CD19 | 1 | 2017 | 12 | 0.140 |
Why?
|
| Fungal Proteins | 2 | 2014 | 72 | 0.140 |
Why?
|
| Lymphopoiesis | 1 | 2017 | 22 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 72 | 0.140 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 563 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 143 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1999 | 95 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 262 | 0.140 |
Why?
|
| Cytokines | 1 | 1999 | 439 | 0.140 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2016 | 1 | 0.140 |
Why?
|
| Computational Biology | 1 | 2018 | 150 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1996 | 24 | 0.140 |
Why?
|
| Prognosis | 2 | 2012 | 759 | 0.140 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 12 | 0.140 |
Why?
|
| Plasmids | 3 | 2004 | 121 | 0.130 |
Why?
|
| Hormones | 1 | 1996 | 41 | 0.130 |
Why?
|
| Conserved Sequence | 2 | 2007 | 54 | 0.130 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2016 | 10 | 0.130 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 119 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 3 | 2019 | 93 | 0.130 |
Why?
|
| Vaccinia virus | 3 | 1995 | 6 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 131 | 0.130 |
Why?
|
| Smad2 Protein | 4 | 2005 | 16 | 0.130 |
Why?
|
| Zebrafish | 2 | 2013 | 95 | 0.120 |
Why?
|
| DNA Primers | 2 | 2012 | 143 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 276 | 0.120 |
Why?
|
| Rats | 3 | 2005 | 1545 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2016 | 150 | 0.120 |
Why?
|
| Genome, Viral | 1 | 1994 | 28 | 0.120 |
Why?
|
| Protein Domains | 3 | 2020 | 48 | 0.120 |
Why?
|
| Magnaporthe | 1 | 2014 | 4 | 0.120 |
Why?
|
| Guanosine Triphosphate | 1 | 2014 | 29 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 23 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 104 | 0.120 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2014 | 29 | 0.120 |
Why?
|
| Endosomes | 1 | 2014 | 44 | 0.120 |
Why?
|
| Benzodiazepinones | 1 | 2014 | 13 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 87 | 0.120 |
Why?
|
| Transcription Factor 4 | 1 | 2014 | 5 | 0.120 |
Why?
|
| Pronephros | 1 | 2013 | 1 | 0.110 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2013 | 22 | 0.110 |
Why?
|
| ets-Domain Protein Elk-4 | 4 | 1997 | 4 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 47 | 0.110 |
Why?
|
| Exosomes | 1 | 2015 | 92 | 0.110 |
Why?
|
| Virus Replication | 1 | 2013 | 55 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2013 | 46 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2009 | 23 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2013 | 59 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2014 | 121 | 0.110 |
Why?
|
| Macromolecular Substances | 3 | 2003 | 52 | 0.110 |
Why?
|
| Wound Healing | 1 | 2014 | 113 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2017 | 624 | 0.110 |
Why?
|
| Indoles | 1 | 2013 | 98 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2014 | 130 | 0.110 |
Why?
|
| Heterochromatin | 1 | 2012 | 7 | 0.100 |
Why?
|
| Sertoli Cells | 1 | 2012 | 2 | 0.100 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2012 | 4 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 33 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 9 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 129 | 0.100 |
Why?
|
| Precipitin Tests | 2 | 2004 | 47 | 0.100 |
Why?
|
| Leukemia | 1 | 2012 | 22 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2013 | 144 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 3 | 2012 | 161 | 0.100 |
Why?
|
| Phosphoserine | 2 | 2002 | 10 | 0.100 |
Why?
|
| Doxorubicin | 1 | 2012 | 74 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2014 | 86 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2008 | 395 | 0.100 |
Why?
|
| Chromatin | 1 | 2012 | 77 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 657 | 0.100 |
Why?
|
| Cell Line, Transformed | 2 | 2003 | 42 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 1991 | 61 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 457 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 408 | 0.090 |
Why?
|
| Mink | 2 | 2001 | 2 | 0.090 |
Why?
|
| Enzyme Activation | 4 | 2001 | 262 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2012 | 282 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 34 | 0.090 |
Why?
|
| Protein Isoforms | 2 | 2014 | 117 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2003 | 131 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 165 | 0.090 |
Why?
|
| Protein Stability | 1 | 2010 | 42 | 0.090 |
Why?
|
| Kinetics | 4 | 2002 | 538 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2007 | 29 | 0.090 |
Why?
|
| Microdissection | 1 | 2009 | 14 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 41 | 0.080 |
Why?
|
| Ecdysone | 1 | 1989 | 2 | 0.080 |
Why?
|
| Peptide Elongation Factors | 1 | 1989 | 5 | 0.080 |
Why?
|
| Insect Hormones | 1 | 1989 | 8 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 67 | 0.080 |
Why?
|
| Prostate | 1 | 2009 | 51 | 0.080 |
Why?
|
| Lasers | 1 | 2009 | 67 | 0.080 |
Why?
|
| Androgens | 1 | 2009 | 47 | 0.080 |
Why?
|
| Peptide Mapping | 2 | 2001 | 22 | 0.080 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2009 | 1 | 0.080 |
Why?
|
| Prostate-Specific Antigen | 1 | 2009 | 51 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 1989 | 61 | 0.080 |
Why?
|
| Cloning, Organism | 1 | 2008 | 2 | 0.080 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2008 | 4 | 0.080 |
Why?
|
| Transcription Factor AP-1 | 2 | 2011 | 26 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 86 | 0.080 |
Why?
|
| Proteolysis | 2 | 2018 | 55 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2008 | 58 | 0.070 |
Why?
|
| Paraganglioma | 1 | 2007 | 2 | 0.070 |
Why?
|
| Succinic Acid | 1 | 2007 | 10 | 0.070 |
Why?
|
| Succinate Dehydrogenase | 1 | 2007 | 7 | 0.070 |
Why?
|
| Ketoglutaric Acids | 1 | 2007 | 16 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 1997 | 25 | 0.070 |
Why?
|
| Mixed Function Oxygenases | 1 | 2007 | 19 | 0.070 |
Why?
|
| Stem Cells | 1 | 2008 | 113 | 0.070 |
Why?
|
| Antibody Specificity | 1 | 2007 | 113 | 0.070 |
Why?
|
| Protein Transport | 1 | 2007 | 152 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 110 | 0.070 |
Why?
|
| Fibroblasts | 3 | 2017 | 152 | 0.070 |
Why?
|
| Antibodies | 1 | 2007 | 124 | 0.070 |
Why?
|
| Middle Aged | 3 | 2014 | 6820 | 0.070 |
Why?
|
| GTP-Binding Proteins | 2 | 1996 | 43 | 0.070 |
Why?
|
| Biological Transport | 2 | 2017 | 111 | 0.070 |
Why?
|
| 3T3 Cells | 3 | 1995 | 44 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2005 | 20 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2007 | 172 | 0.060 |
Why?
|
| 3' Flanking Region | 1 | 2005 | 1 | 0.060 |
Why?
|
| Polyadenylation | 1 | 2005 | 1 | 0.060 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 5 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2005 | 9 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 305 | 0.060 |
Why?
|
| Exons | 1 | 2005 | 41 | 0.060 |
Why?
|
| Introns | 1 | 2005 | 41 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2005 | 24 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 42 | 0.060 |
Why?
|
| Cell Survival | 3 | 2014 | 394 | 0.060 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2004 | 1 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2004 | 1 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2004 | 1 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 30 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2004 | 32 | 0.060 |
Why?
|
| E-Box Elements | 1 | 2003 | 1 | 0.060 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2003 | 1 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2003 | 27 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2003 | 7 | 0.060 |
Why?
|
| Histone Deacetylase 1 | 1 | 2003 | 10 | 0.060 |
Why?
|
| Histone Deacetylase 2 | 1 | 2003 | 10 | 0.060 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2003 | 31 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2004 | 82 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2004 | 115 | 0.060 |
Why?
|
| Histone Deacetylases | 1 | 2003 | 22 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2003 | 100 | 0.050 |
Why?
|
| Imidazoles | 1 | 2003 | 60 | 0.050 |
Why?
|
| Protein Conformation | 2 | 1996 | 250 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 453 | 0.050 |
Why?
|
| RNA | 1 | 2004 | 105 | 0.050 |
Why?
|
| Pyridines | 1 | 2003 | 99 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 25 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2002 | 25 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 62 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 118 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2002 | 27 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2002 | 16 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 100 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 49 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2001 | 3 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1995 | 24 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2019 | 148 | 0.050 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2020 | 1 | 0.050 |
Why?
|
| Nucleosomes | 1 | 2020 | 18 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 66 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 102 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 110 | 0.040 |
Why?
|
| Smad1 Protein | 1 | 1999 | 3 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2000 | 23 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2001 | 240 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 13 | 0.040 |
Why?
|
| Avian Sarcoma Viruses | 2 | 2000 | 4 | 0.040 |
Why?
|
| Receptors, OSM-LIF | 1 | 1999 | 1 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 1999 | 4 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1999 | 5 | 0.040 |
Why?
|
| Adult | 3 | 2014 | 7384 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1999 | 5 | 0.040 |
Why?
|
| Lymphokines | 1 | 1999 | 8 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 1999 | 11 | 0.040 |
Why?
|
| Nitrobenzoates | 1 | 2019 | 7 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1999 | 21 | 0.040 |
Why?
|
| Pyrans | 1 | 2019 | 8 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 80 | 0.040 |
Why?
|
| Circadian Clocks | 1 | 2018 | 1 | 0.040 |
Why?
|
| ARNTL Transcription Factors | 1 | 2018 | 2 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 2 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 64 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 1999 | 32 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 1999 | 29 | 0.040 |
Why?
|
| F-Box Proteins | 1 | 2018 | 10 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 133 | 0.040 |
Why?
|
| Smad4 Protein | 1 | 1998 | 5 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 109 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1998 | 10 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 1999 | 105 | 0.040 |
Why?
|
| Serine | 1 | 1998 | 48 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 75 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 131 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 111 | 0.040 |
Why?
|
| Child | 1 | 2004 | 2146 | 0.040 |
Why?
|
| Hydrolysis | 2 | 2014 | 58 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 22 | 0.040 |
Why?
|
| Models, Molecular | 3 | 1996 | 441 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2017 | 10 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 1997 | 4 | 0.040 |
Why?
|
| Insulin | 1 | 1999 | 310 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2017 | 11 | 0.040 |
Why?
|
| Point Mutation | 2 | 1996 | 60 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2004 | 2264 | 0.040 |
Why?
|
| Karyotyping | 1 | 1997 | 24 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 72 | 0.040 |
Why?
|
| Arginine | 1 | 2017 | 39 | 0.040 |
Why?
|
| Phosphopeptides | 1 | 1997 | 11 | 0.040 |
Why?
|
| Chickens | 1 | 2017 | 59 | 0.040 |
Why?
|
| Adolescent | 1 | 2004 | 2957 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1999 | 290 | 0.040 |
Why?
|
| COS Cells | 1 | 1996 | 48 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1997 | 83 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2016 | 8 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2017 | 134 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1996 | 23 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2002 | 46 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 50 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 80 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1994 | 38 | 0.030 |
Why?
|
| TATA Box | 2 | 1995 | 2 | 0.030 |
Why?
|
| rab27 GTP-Binding Proteins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Oncogene Proteins v-sis | 1 | 1995 | 1 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 274 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1994 | 4 | 0.030 |
Why?
|
| Genes, Immediate-Early | 1 | 1994 | 5 | 0.030 |
Why?
|
| Herpesviridae | 1 | 1994 | 3 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 1994 | 21 | 0.030 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2014 | 2 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1994 | 50 | 0.030 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2014 | 6 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 32 | 0.030 |
Why?
|
| Plant Diseases | 1 | 2014 | 36 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 123 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Oryza | 1 | 2014 | 37 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 37 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 16 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1994 | 45 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 50 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 26 | 0.030 |
Why?
|
| Endocytosis | 1 | 2014 | 81 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2014 | 46 | 0.030 |
Why?
|
| Hair Follicle | 1 | 2014 | 8 | 0.030 |
Why?
|
| Lithium | 1 | 2014 | 8 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 29 | 0.030 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 1993 | 1 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1993 | 17 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2014 | 40 | 0.030 |
Why?
|
| Models, Genetic | 1 | 1994 | 123 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2013 | 15 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 30 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1993 | 110 | 0.030 |
Why?
|
| Mammals | 1 | 2013 | 46 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 239 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 90 | 0.030 |
Why?
|
| Microcirculation | 1 | 2014 | 111 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 147 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2013 | 68 | 0.030 |
Why?
|
| Temperature | 1 | 1994 | 207 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2013 | 104 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1992 | 32 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 144 | 0.030 |
Why?
|
| Skin | 1 | 2014 | 140 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 747 | 0.030 |
Why?
|
| Laser Scanning Cytometry | 1 | 2012 | 1 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2012 | 9 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 324 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1993 | 197 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 130 | 0.030 |
Why?
|
| Genome | 1 | 2012 | 53 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 63 | 0.030 |
Why?
|
| Chromosomes | 1 | 2012 | 59 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 47 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1991 | 31 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 26 | 0.020 |
Why?
|
| Drosophila | 1 | 1991 | 32 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2014 | 328 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2012 | 121 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1991 | 261 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 238 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 322 | 0.020 |
Why?
|
| Mesoderm | 1 | 2008 | 12 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2008 | 4 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Dipeptides | 1 | 2008 | 22 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2008 | 44 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2008 | 43 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 55 | 0.020 |
Why?
|
| Organisms, Genetically Modified | 1 | 2007 | 5 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2007 | 8 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2007 | 14 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 65 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2008 | 58 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2007 | 40 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 340 | 0.020 |
Why?
|
| rap GTP-Binding Proteins | 2 | 1996 | 3 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 1996 | 3 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 278 | 0.020 |
Why?
|
| Crystallography, X-Ray | 2 | 1996 | 214 | 0.020 |
Why?
|
| Cyclins | 1 | 2002 | 8 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2002 | 20 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 17 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 29 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 69 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 190 | 0.010 |
Why?
|
| Terminal Repeat Sequences | 1 | 2000 | 2 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 1999 | 8 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1999 | 7 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 1998 | 1 | 0.010 |
Why?
|
| Cell Death | 1 | 1998 | 110 | 0.010 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 1997 | 1 | 0.010 |
Why?
|
| Activating Transcription Factor 2 | 1 | 1997 | 4 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 76 | 0.010 |
Why?
|
| Oncogene Proteins v-myb | 1 | 1996 | 2 | 0.010 |
Why?
|
| Guanylyl Imidodiphosphate | 1 | 1996 | 2 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1996 | 43 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 1996 | 1 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 200 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1995 | 20 | 0.010 |
Why?
|
| Transcription Factor TFIID | 1 | 1995 | 2 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1994 | 13 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1994 | 106 | 0.010 |
Why?
|